Rising crude oil prices lifted the markets to a sharply higher open with the Dow soaring 159 points to 17,865. Nasdaq gained 17 points to 4,767.
On the upside
ChemoCentryx (Nasdaq: CCXI) entered a strategic license agreement for Vifor Pharm to commercialize CCX168 outside the U.S. and most of Asia.
Crocs (Nasdaq: CROX) reversed year ago losses to post a greater than expected profit for the first quarter.
MaxLinear (NYSE: MXL) swung to a better than expected profit for the first quarter.
On the downside
SolarCity (Nasdaq: SCTY) widened first quarter losses more than expected and slashed its solar panel installation forecast.
NewLink Genetics (Nasdaq: NLNK) reported disappointing results from a Phase 3 clinical trial of its resected pancreatic cancer treatment algenpantucel-L.
MannKind (Nasdaq: MNKD) priced its registered direct public offering of common stock and warrants.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 climbed 13 points to 2,072. Bitcoin lost $4 to $451.
